Dr. Darryl F. Cannady II, MD

Dr. Cannady practices at South Florida Orthopaedics & Sports Medicine, PA in Port Saint Lucie, Florida.

Dr. Cannady's NPI, 1538518824, was assigned on June 7, 2016. Dr. Cannady graduated from University of Miami, Miller School of Medicine in 2016. Dr. Cannady holds Florida license ME157348.

Dr. Cannady's primary practice is South Florida Orthopaedics & Sports Medicine, PA, at 9401 SW Discovery Way, Port Saint Lucie, FL 34987 in Saint Lucie County. The practice phone is (772) 288-2400.

Dr. Cannady's primary practice is South Florida Orthopaedics & Sports Medicine, PA in Port Saint Lucie, Florida. Dr. Cannady is also affiliated with HCA Florida St. Lucie Hospital. The medical group on file is South Florida Orthopaedics & Sports Medicine. Dmand AI also links Dr. Cannady to 2 more hospitals, 5 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cannady practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Cannady's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Cannady is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Cannady's licenses on file in 2 states: Florida and California.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, hip replacement, joint pain, knee arthroscopy and knee fracture and dislocation among the conditions Dr. Cannady treats.

CMS data shows 19,630 Medicare services from Dr. Cannady across 26 procedure codes in 2024, for 860 Medicare patients. Medicare paid $279,130 for them.

CMS counts 860 Medicare patients who saw Dr. Cannady in 2024. The largest group is 65 to 74, with 366 patients. 75% of them have arthritis, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cannady's median patient age at 70, with 60% women.

In 2024, Dr. Cannady wrote 1,479 Medicare Part D claims for 456 patients. 99% of them were for generic drugs. CMS names the drug for 1,454 of them, across 14 drugs with 11 or more claims each, at $15,115 in total drug cost. In 2023, CMS named 981 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Cannady for performance year 2024, reported as part of a group. Dr. Cannady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 49 procedures of hip replacement by Dr. Cannady, more than 87% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Cannady, published from 2011 to 2021. The most frequent topics are Testosterone. Dr. Cannady's most frequent co-authors are Joseph A. Bernardo, MD and Joshua R. Langford, MD.

CMS Open Payments shows 237 general payments to Dr. Cannady from 18 drug and device companies from 2016 to 2025. Education make up the largest share, 47% of the total. Smith & Nephew, Inc. paid the most, $19,875.

Dmand AI lists 1 award for Dr. Cannady, most recently SNMA Member of the Year in 2014.

Dr. Cannady graduated from University of Miami, Miller School of Medicine in 2016. Dr. Cannady is a member of AAOS, AAHKS and J. Robert Gladden Orthopedic Society.

Dr. Cannady is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.